Contiguous gene deletion syndrome, characterized by both TSC and polycystic kidney disease, affects up to 5% of TSC patients [2] and has been diagnosed in the two patients with TSC2 segmental deletions encompassing PKD1 exon 46, assisted in a multispecialty clinic. This evidence concerns the gene PKD1 and Down syndrome.